<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00787280</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00002610</org_study_id>
    <nct_id>NCT00787280</nct_id>
  </id_info>
  <brief_title>Diet, Imaging and Energy Balance Trial (DIET)</brief_title>
  <acronym>DIET</acronym>
  <official_title>Diet, Imaging and Energy Balance Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Robert C. Atkins Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate whether changes in macronutrient consumption (i.e., switching to a diet low in&#xD;
      carbohydrates) can change brain responses to cues depicting foods representing that&#xD;
      macronutrient. In addition to answering specific questions regarding the effects of an LCKD,&#xD;
      the study will provide general information about relations between brain responses to food&#xD;
      cues and a broad arrive of factors including typical diet, food preferences, weight control&#xD;
      history and genes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose a parallel arm randomized clinical trial of two diets-a low carbohydrate ketogenic&#xD;
      diet (LCKD) and a low fat diet (LFD). Following screening, eligible participants will undergo&#xD;
      a six week dietary intervention that will include 7 clinic visits at the Duke Lifestyle&#xD;
      Medicine Clinic (Director: Dr. Westman). In addition to the dietary intervention,&#xD;
      participants will undergo fMRI scanning on two occasions: once in the week prior to&#xD;
      randomization to a diet (Baseline Scan) and after three weeks of following a diet (Post-Diet&#xD;
      Scan). During scanning participants will view food cues in order to assess the effects of&#xD;
      diet on brain responses to different macronutrient content categories (e.g., High vs. Low&#xD;
      Complex Carbohydrate). In addition to scanning measures, we will also record information&#xD;
      regarding dietary intake, food preferences, weight, mood, and diet adherence.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compared to individuals in the LFD group, individuals placed on an LCKD will exhibit decreased brain responses to high-carbohydrate food cues.</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>In addition to these questions, we will also examine relations between food consumption acquired from the diaries, genetic factors and brain function.</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Low Carbohydrate Ketogenic Diet (LCKD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will follow a low carbohydrate ketogenic diet for six weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Fat Diet (LFD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>particpants will follow a low fat diet for six weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low Carbohydrate Ketogenic Diet (LCKD)</intervention_name>
    <description>participants will follow a low carbohydrate ketogenic diet for six weeks</description>
    <arm_group_label>Low Carbohydrate Ketogenic Diet (LCKD)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low Fat Diet (LFD)</intervention_name>
    <description>particpants will follow a low fat diet for six weeks</description>
    <arm_group_label>Low Fat Diet (LFD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Participants must be 18-50 years old, right handed and have a BMI &gt; 27 kg/mÂ². They must be&#xD;
        willing to follow either of the two diets.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. weigh over 300lbs.&#xD;
&#xD;
          2. have uncontrolled hypertension (systolic &gt;160mm Hg, diastolic &gt;100mm Hg)&#xD;
&#xD;
          3. have hypotension (systolic &lt;90 mm Hg, diastolic &lt;60 mm Hg)&#xD;
&#xD;
          4. have coronary heart disease, or cardiac rhythm disorder&#xD;
&#xD;
          5. cerebrovascular disease or peripheral vascular disease that requires intensive&#xD;
             hyperlipidemic therapy&#xD;
&#xD;
          6. other significant co-morbid illnesses such as liver disease (AST or ALT &gt; 100), kidney&#xD;
             disease (serum creatinine &gt; 1.5), cancer, severe emphysema, severe&#xD;
             hypertriglyceridemia (TG&gt;500)&#xD;
&#xD;
          7. have diabetes (insulin or diet controlled)&#xD;
&#xD;
          8. have a current psychiatric disease&#xD;
&#xD;
          9. have current alcohol abuse (greater than 12 drinks per week)&#xD;
&#xD;
         10. have current drug abuse (or treatment within the last year)&#xD;
&#xD;
         11. use of psychiatric medications (including antidepressants, anti-anxiety agents,&#xD;
             anti-psychotics, &quot;muscle relaxants&quot; or any other drug that influences mood, cognition,&#xD;
             or neurotransmitter systems, i.e. dopamine, norepinephrine, acetylcholine, serotonin,&#xD;
             GABA, and glutamate)&#xD;
&#xD;
         12. have had or have an eating disorder including anorexia nervosa, bulimia nervosa,&#xD;
             eating disorder not otherwise specified, binge eating disorder, or any other form of&#xD;
             disordered eating&#xD;
&#xD;
         13. have had any bariatric/weight loss surgery&#xD;
&#xD;
         14. be taking any diet pills (prescription or over the counter)&#xD;
&#xD;
         15. have been on any diet in the last 3 months&#xD;
&#xD;
         16. have any restrictive dietary requirements (including: vegetarians, vegans, or any&#xD;
             other dietary restraints)&#xD;
&#xD;
         17. have any food allergies&#xD;
&#xD;
         18. be on an exclusively ethnic diet&#xD;
&#xD;
         19. be females who are pregnant, nursing mothers or likely to become pregnant&#xD;
&#xD;
         20. have any major medical condition that would make participation unsafe (e.g., have&#xD;
             pacemaker or other metallic implant (including dental, orthopedic, or IUD),&#xD;
             uncomfortable (e.g., chronic pain), confound results (e.g., psychiatric condition)&#xD;
&#xD;
         21. be left handed&#xD;
&#xD;
         22. have glaucoma, color blindness&#xD;
&#xD;
         23. be using experimental or investigational drugs&#xD;
&#xD;
         24. or suffering from claustrophobia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francis J McClernon, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <study_first_submitted>November 6, 2008</study_first_submitted>
  <study_first_submitted_qc>November 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2008</study_first_posted>
  <last_update_submitted>February 18, 2013</last_update_submitted>
  <last_update_submitted_qc>February 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>obese</keyword>
  <keyword>overweight</keyword>
  <keyword>fMRI</keyword>
  <keyword>Diet</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

